Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC

Cannabis sativa (Cannabis) is one of the world’s most well-known, yet maligned plant species. However, significant recent research starting to unveil potential produce secondary compounds that may offer a suite medical benefits, elevating this unique species from its illicit narcotic status into genuine biopharmaceutical. This review summarises lengthy history and details molecular pathways underpin production key metabolites confer efficacy. We also provide an up-to-date summary targets relatively unknown minor offered by plant. Furthermore, we detail advances in science, as well synthetic biology, pharmacology surrounding Cannabis. Given relative infancy research, go on highlight parallels previous conducted another medically relevant versatile plant, Papaver somniferum (opium poppy), indicator possible future direction biology. Overall, highlights directions cannabis outside biology aspects well-characterised constituents explores additional avenues for improvement